Search

Your search keyword '"Peacock, Andrew"' showing total 1,021 results

Search Constraints

Start Over You searched for: Author "Peacock, Andrew" Remove constraint Author: "Peacock, Andrew"
1,021 results on '"Peacock, Andrew"'

Search Results

53. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements

54. Recuerdo De Huautla: An Odyssey of Inner Space

55. The REPAIR Study Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension

56. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

57. Abstract 14753: Loss of Function ABCC8 Mutations Are Associated With Pulmonary Arterial Hypertension

58. The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension

59. Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

63. Function of the Right Ventricle

65. The REPAIR Study

66. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)

68. Whole-genome sequencing of patients with rare diseases in a national health system

70. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

73. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial

74. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension

75. Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar

80. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

81. Physiology of the Normal Pulmonary Circulation

82. The right ventricle in congenital heart diseases

88. SWITCHING TO RIOCIGUAT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION NOT AT TREATMENT GOAL WITH PHOSPHODIESTERASE TYPE-5 INHIBITORS: SUBGROUP ANALYSIS RESULTS OF THE REPLACE STUDY

89. Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction

91. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

92. COMPARISON OF STANDARDIZED TREATMENT EFFECT SIZES FOR INVASIVE AND NON-INVASIVE ENDPOINTS IN PULMONARY ARTERIAL HYPERTENSION: INSIGHTS FROM THE REPAIR STUDY

94. Publisher Correction:Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)

95. Whole-genome sequencing of a sporadic primary immunodeficiency cohort

96. Whole-genome sequencing of patients with rare diseases in a national health system

98. sj-pdf-1-pul-10.1177_2045894020922810 - Supplemental material for Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension

99. PUL897513 Supplemental material - Supplemental material for Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen–hypoxia rat model by cardiac magnetic resonance imaging

100. Energy related practices in Mediterranean low income housing

Catalog

Books, media, physical & digital resources